Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ann Berman Insider Profile
4 Followers
Ann Berman, Director at Cantel Medical, holds 5.00K shares in Loews (Ticker: L), holds 67.47K shares in Immuneering (Ticker: IMRX), holds 4.16K shares in Cantel Medical (Ticker: CMD).
Profitable Transactions
6 out of 28 Profitable Transactions
Average Return
-14.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
The most profitable trade made by Ann Berman
Ann Berman's Trading History
Cantel Medical
Apr 06, 2021
―
Informative Sell
453.25K
$334.26K
Immuneering
Mar 19, 2024
Director
Informative Buy
122.89K
$140.33K
Eaton Vance
Nov 02, 2015
―
Informative Sell
45.46K
$0.00
Loews
Sep 04, 2024
Director
Uninformative Buy
94.45K
$428.98K
List of latest transactions for each holding click on a transaction to see Ann Berman's performance on stock
You May Also Like
Ann Berman insider profile FAQ
What is the percentage of profitable transactions made by Ann Berman?
The percentage of profitable transactions made by Ann Berman is 21%.
What is the average return per transaction made by Ann Berman?
The average return per transaction made by Ann Berman is -14.80%.
What stocks does Ann Berman hold?
Ann Berman holds: CMD, IMRX, ~EV, L stocks.
What was Ann Berman’s latest transaction?
Ann Berman latest transaction was an Uninformative Buy of $94.45K.
What was Ann Berman's most profitable transaction?
Ann Berman’s most profitable transaction was an Informative Buy of IMRX stock on March 15, 2022. The return on the trade was 18.40%.
What is Ann Berman's role in Cantel Medical?
Ann Berman's role in Cantel Medical is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.